UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.191

Sortiert nach

Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19

Neurology, 2020-09, Vol.95 (12), p.e1754

2020

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 replication in the central nervous system occurs in two distinct cell types

PLoS pathogens, 2011-10, Vol.7 (10), p.e1002286-e1002286

2011

Link zum Volltext

Verfügbarkeit prüfen

The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?

BMC infectious diseases, 2011-12, Vol.11 (1), p.356-356, Article 356

2011

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 Viral Escape in Cerebrospinal Fluid of Subjects on Suppressive Antiretroviral Treatment

The Journal of infectious diseases, 2010-12, Vol.202 (12), p.1819-1825

2010

Link zum Volltext

Verfügbarkeit prüfen

Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients

PloS one, 2014-02, Vol.9 (2), p.e88591-e88591

2014

Link zum Volltext

Verfügbarkeit prüfen

Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection

PLoS pathogens, 2015-03, Vol.11 (3), p.e1004720-e1004720

2015

Link zum Volltext

Verfügbarkeit prüfen

Large Differences in Small RNA Composition Between Human Biofluids

Cell reports (Cambridge), 2018-10, Vol.25 (5), p.1346-1358

2018

Link zum Volltext

Verfügbarkeit prüfen

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study

EBioMedicine, 2016-01, Vol.3 (C), p.135-140

2016

Link zum Volltext

Verfügbarkeit prüfen

Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate

PloS one, 2019-12, Vol.14 (12), p.e0226276

2019

Link zum Volltext

Verfügbarkeit prüfen

Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment

PloS one, 2016-06, Vol.11 (6), p.e0157160-e0157160

2016

Link zum Volltext

Verfügbarkeit prüfen

Antiretroviral Therapy and Central Nervous System HIV Type 1 Infection

The Journal of Infectious Diseases, 2008-05, Vol.197 (Supplement-3), p.S294-S306

2008

Link zum Volltext

Verfügbarkeit prüfen

Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection

PloS one, 2014-12, Vol.9 (12), p.e116081-e116081

2014

Link zum Volltext

Verfügbarkeit prüfen

Compartmentalization and Clonal Amplification of HIV-1 Variants in the Cerebrospinal Fluid during Primary Infection

Journal of Virology, 2010-03, Vol.84 (5), p.2395-2407

2010

Link zum Volltext

Verfügbarkeit prüfen

Herpes zoster in HIV-1 infection: The role of CSF pleocytosis in secondary CSF escape and discordance

PloS one, 2020-07, Vol.15 (7), p.e0236162-e0236162

2020

Link zum Volltext

Verfügbarkeit prüfen

Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression

PloS one, 2021-05, Vol.16 (5), p.e0250987-e0250987

2021

Link zum Volltext

Verfügbarkeit prüfen

Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia

PLoS pathogens, 2009-04, Vol.5 (4), p.e1000395-e1000395

2009

Link zum Volltext

Verfügbarkeit prüfen

Immune Activation of the Central Nervous System Is Still Present after >4 Years of Effective Highly Active Antiretroviral Therapy

The Journal of infectious diseases, 2007-12, Vol.196 (12), p.1779-1783

2007

Link zum Volltext

Verfügbarkeit prüfen

Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy

Current HIV/AIDS reports, 2015-06, Vol.12 (2), p.280-288

2015

Link zum Volltext

Verfügbarkeit prüfen

Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection

AIDS research and therapy, 2010-06, Vol.7 (1), p.15-15

2010

Link zum Volltext

Verfügbarkeit prüfen

Progressive multifocal leukoencephalopathy in HIV-1 infection

The Lancet infectious diseases, 2009-10, Vol.9 (10), p.625-636

2009

Link zum Volltext

Verfügbarkeit prüfen

Cellular Composition of Cerebrospinal Fluid in HIV-1 Infected and Uninfected Subjects

PloS one, 2013-06, Vol.8 (6), p.e66188-e66188

2013

Link zum Volltext

Verfügbarkeit prüfen

Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection

BMC neurology, 2021-12, Vol.21 (1), p.494-494, Article 494

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.191

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.091)
Mit Volltextzugriff
(1.022)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

MEDLINE
(691)
EZB Electronic Journals Library
(607)
Ingenta
(487)
RCN full-text journals@Ovid
(476)
Single Journals
(376)
IngentaConnect Journals
(243)
Elsevier ScienceDirect Journals Complete
(220)
Wiley-Blackwell Journals
(144)
Elsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)
(144)
JSTOR All Journals
(137)
Wiley Online Library
(103)
Oxford Journals
(87)
SpringerLink
(68)
Oxford Journals 2020 Medicine
(67)
Nature
(61)
PBSC : Psychology and Behavioral Sciences Collection - Journals
(52)
Taylor & Francis Online
(45)
Taylor & Francis Current Content Access
(41)
Nexis
(40)
eBooks on EBSCOhost
(36)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19

HIV-1 replication in the central nervous system occurs in two distinct cell types

The definition of HIV-associated neurocognitive disorders: are we overestimating the real prevalence?

HIV-1 Viral Escape in Cerebrospinal Fluid of Subjects on Suppressive Antiretroviral Treatment

Biomarker evidence of axonal injury in neuroasymptomatic HIV-1 patients

Challenges in detecting HIV persistence during potentially curative interventions: a study of the Berlin patient

Compartmentalized replication of R5 T cell-tropic HIV-1 in the central nervous system early in the course of infection

HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: An observational study

Large Differences in Small RNA Composition Between Human Biofluids

Plasma Concentration of the Neurofilament Light Protein (NFL) is a Biomarker of CNS Injury in HIV Infection: A Cross-Sectional Study

Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate

Increased Intrathecal Immune Activation in Virally Suppressed HIV-1 Infected Patients with Neurocognitive Impairment

Antiretroviral Therapy and Central Nervous System HIV Type 1 Infection

Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection

Compartmentalization and Clonal Amplification of HIV-1 Variants in the Cerebrospinal Fluid during Primary Infection

Herpes zoster in HIV-1 infection: The role of CSF pleocytosis in secondary CSF escape and discordance

Compartmentalization of cerebrospinal fluid inflammation across the spectrum of untreated HIV-1 infection, central nervous system injury and viral suppression

Compartmentalized human immunodeficiency virus type 1 originates from long-lived cells in some subjects with HIV-1-associated dementia

Immune Activation of the Central Nervous System Is Still Present after >4 Years of Effective Highly Active Antiretroviral Therapy

Cerebrospinal Fluid HIV Escape from Antiretroviral Therapy

Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection

Progressive multifocal leukoencephalopathy in HIV-1 infection

Sirtuin-2, NAD-Dependent Deacetylase, Is a New Potential Therapeutic Target for HIV-1 Infection and HIV-Related Neurological Dysfunction

Cellular Composition of Cerebrospinal Fluid in HIV-1 Infected and Uninfected Subjects

Effect of antiretroviral treatment on blood-brain barrier integrity in HIV-1 infection

Suchergebnisse filtern